References
- Webber NK, Robson A, Macmahon E, . Severe perianal ulceration. BMJ 2010;340:c2157.
- Katory M, Davies B, Kelty C, . Nicorandil and idiopathic anal ulceration. Dis Colon Rectum 2005;48:1442–1446.
- Frydman A. Pharmacokinetic profile of nicorandil in humans: an overview. J Cardiovasc Pharmacol 1992;20(Suppl. 3):S34–S44.
- Scottish Intercollegiate Guidelines Network. Management of chronic stable angina. Edinburgh: SIGN; 2007.
- IONA Study Group. Effect of nicorandil on coronary events in patients with stable angina: the Impact of Nicorandil in Angina (IONA) randomised trial. Lancet 2002;359:1269–1275.
- Claeys A, Weber-Muller F, Trechot P, . Cutaneous, perivulvar and perianal ulcerations induced by nicorandil. Br J Dermatol 2006;155:494–496.
- Tiernan JP, Baraza W, Chelham W, . Nicorandil induced perianal ulceration. JNMA J Nepal Med Assoc 2009;48:239–241.
- Toquero L, Briggs CD, Bassuini MM, . Anal ulceration associated with nicorandil: case series and review of the literature. Colorectal Dis 2006;8:717–720.
- Lampe FC, Morris RW, Walker M, . Trends in rates of different forms of diagnosed coronary heart disease, 1978 to 2000: prospective, population based study of British men. BMJ 2005;330:1046.
- Tunstall-Pedoe H, Kuulasmaa K, Mahonen M, . Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations. Monitoring trends and determinants in cardiovascular disease. Lancet 1999;353:1547–1557.